申请人:Demong Duane Eugene
                            
                            
                                公开号:US20100249144A1
                            
                            
                                公开(公告)日:2010-09-30
                            
                            Compounds of Formula (I) or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB
1
receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.